These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22266083)

  • 21. [Neurological complications of Fabry-disease].
    Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
    Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons from two cases: is Fabry disease the correct diagnosis?
    Kiykim E; Zeybek CA; Zubarioglu T; Aydin A
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25969484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabry disease.
    Tarabuso AL
    Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age adjusting severity scores for Anderson-Fabry disease.
    Hughes DA; Ramaswami U; Barba Romero MÁ; Deegan P;
    Mol Genet Metab; 2010; 101(2-3):219-27. PubMed ID: 20691627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
    Lara B; Miravitlles M
    COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity.
    Allen LE; Cosgrave EM; Kersey JP; Ramaswami U
    Br J Ophthalmol; 2010 Dec; 94(12):1602-5. PubMed ID: 20576773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
    Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
    Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudoacromegalic facial features in Fabry disease.
    Hogarth V; Hughes D; Orteu CH
    Clin Exp Dermatol; 2013 Mar; 38(2):137-9. PubMed ID: 22731890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease.
    Beck M
    Acta Paediatr Suppl; 2006 Apr; 95(451):43-6. PubMed ID: 16720464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey.
    Lidove O; Ramaswami U; Jaussaud R; Barbey F; Maisonobe T; Caillaud C; Beck M; Sunder-Plassmann G; Linhart A; Mehta A;
    Int J Clin Pract; 2006 Sep; 60(9):1053-9. PubMed ID: 16939546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A successful approach for the detection of Fabry patients in Argentina.
    Rozenfeld PA; Tarabuso A; Ebner R; Ramallo G; Fossati CA
    Clin Genet; 2006 Apr; 69(4):344-8. PubMed ID: 16630168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening.
    Bouwman MG; de Ru MH; Linthorst GE; Hollak CE; Wijburg FA; van Zwieten MC
    Mol Genet Metab; 2013 Jun; 109(2):201-7. PubMed ID: 23566439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misdiagnosis in Fabry disease.
    Marchesoni CL; Roa N; Pardal AM; Neumann P; Cáceres G; Martínez P; Kisinovsky I; Bianchi S; Tarabuso AL; Reisin RC
    J Pediatr; 2010 May; 156(5):828-31. PubMed ID: 20385321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.
    van der Tol L; Svarstad E; Ortiz A; Tøndel C; Oliveira JP; Vogt L; Waldek S; Hughes DA; Lachmann RH; Terryn W; Hollak CE; Florquin S; van den Bergh Weerman MA; Wanner C; West ML; Biegstraaten M; Linthorst GE
    Mol Genet Metab; 2015 Feb; 114(2):242-7. PubMed ID: 25187469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
    Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
    Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interdisciplinary approach towards female patients with Fabry disease.
    Weidemann F; Niemann M; Sommer C; Beer M; Breunig F; Wanner C
    Eur J Clin Invest; 2012 Apr; 42(4):455-62. PubMed ID: 22049975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.